New stroke drug shows promise in early safety trial
NCT ID NCT05403866
First seen Jan 03, 2026 · Last updated May 17, 2026 · Updated 23 times
Summary
This study tested a new drug called LT3001 in 89 people who had an acute ischemic stroke (a stroke caused by a blood clot). The goal was to see if the drug is safe and if it helps patients recover. Participants received either the drug or a placebo within 24 hours of their stroke. The study found no major safety concerns related to the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chattanooga Center for Neurologic Research
Chattanooga, Tennessee, 37403, United States
Conditions
Explore the condition pages connected to this study.